Home/Filings/4/0001127602-22-006283
4//SEC Filing

Brennan Troyen A 4

Accession 0001127602-22-006283

CIK 0000064803other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:22 PM ET

Size

13.9 KB

Accession

0001127602-22-006283

Insider Transaction Report

Form 4
Period: 2022-02-21
Brennan Troyen A
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-02-21+171,944312,815.059 total
Holdings
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (80,803 underlying)
    80,803
  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01Common Stock (21,894 underlying)
    21,894
  • Common Stock (restricted)

    4,805
  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01Common Stock (53,772 underlying)
    53,772
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (99,344 underlying)
    99,344
  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03Common Stock (75,134 underlying)
    75,134
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (84,478 underlying)
    84,478
Footnotes (8)
  • [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
  • [F2]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F6]The number of shares subject to the option were calculated using a 30-day average price.
  • [F7]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F8]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001351402

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:22 PM ET
Size
13.9 KB